366 related articles for article (PubMed ID: 17082242)
1. Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy.
Tan X; Li Y; Liu Y
J Am Soc Nephrol; 2006 Dec; 17(12):3382-93. PubMed ID: 17082242
[TBL] [Abstract][Full Text] [Related]
2. Ursolic acid inhibits epithelial-mesenchymal transition in vitro and in vivo.
Xu CG; Zhu XL; Wang W; Zhou XJ
Pharm Biol; 2019 Dec; 57(1):169-175. PubMed ID: 30905239
[TBL] [Abstract][Full Text] [Related]
3. The T-box transcription factor Brachyury promotes renal interstitial fibrosis by repressing E-cadherin expression.
Sun S; Sun W; Xia L; Liu L; Du R; He L; Li R; Wang H; Huang C
Cell Commun Signal; 2014 Nov; 12():76. PubMed ID: 25433496
[TBL] [Abstract][Full Text] [Related]
4. HSP72 attenuates renal tubular cell apoptosis and interstitial fibrosis in obstructive nephropathy.
Mao H; Li Z; Zhou Y; Li Z; Zhuang S; An X; Zhang B; Chen W; Nie J; Wang Z; Borkan SC; Wang Y; Yu X
Am J Physiol Renal Physiol; 2008 Jul; 295(1):F202-14. PubMed ID: 18417540
[TBL] [Abstract][Full Text] [Related]
5. Renoprotective effects of paricalcitol on gentamicin-induced kidney injury in rats.
Park JW; Bae EH; Kim IJ; Ma SK; Choi C; Lee J; Kim SW
Am J Physiol Renal Physiol; 2010 Feb; 298(2):F301-13. PubMed ID: 19940033
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis.
Li Y; Tan X; Dai C; Stolz DB; Wang D; Liu Y
J Am Soc Nephrol; 2009 Sep; 20(9):1907-18. PubMed ID: 19541809
[TBL] [Abstract][Full Text] [Related]
7. Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling.
Tan X; Wen X; Liu Y
J Am Soc Nephrol; 2008 Sep; 19(9):1741-52. PubMed ID: 18525004
[TBL] [Abstract][Full Text] [Related]
8. Paricalcitol protects against TGF-β1-induced fibrotic responses in hypoxia and stabilises HIF-α in renal epithelia.
Nolan KA; Brennan EP; Scholz CC; Cullen C; Ryan A; Taylor CT; Godson C
Exp Cell Res; 2015 Jan; 330(2):371-381. PubMed ID: 25107382
[TBL] [Abstract][Full Text] [Related]
9. Leukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal mice.
Lange-Sperandio B; Trautmann A; Eickelberg O; Jayachandran A; Oberle S; Schmidutz F; Rodenbeck B; Hömme M; Horuk R; Schaefer F
Am J Pathol; 2007 Sep; 171(3):861-71. PubMed ID: 17675578
[TBL] [Abstract][Full Text] [Related]
10. Paricalcitol attenuates 4-hydroxy-2-hexenal-induced inflammation and epithelial-mesenchymal transition in human renal proximal tubular epithelial cells.
Kim CS; Joo SY; Lee KE; Choi JS; Bae EH; Ma SK; Kim SH; Lee J; Kim SW
PLoS One; 2013; 8(5):e63186. PubMed ID: 23690997
[TBL] [Abstract][Full Text] [Related]
11. Hirsutella sinensis Attenuates Aristolochic Acid-Induced Renal Tubular Epithelial-Mesenchymal Transition by Inhibiting TGF-β1 and Snail Expression.
Xu XY; Chai JJ; Chen YP; Rui HL; Wang YY; Dong HR; Man YL; Cheng H
PLoS One; 2016; 11(2):e0149242. PubMed ID: 26890569
[TBL] [Abstract][Full Text] [Related]
12. Opposite role of CD44-standard and CD44-variant-3 in tubular injury and development of renal fibrosis during chronic obstructive nephropathy.
Rampanelli E; Rouschop KM; Claessen N; Teske GJ; Pals ST; Leemans JC; Florquin S
Kidney Int; 2014 Sep; 86(3):558-69. PubMed ID: 24717295
[TBL] [Abstract][Full Text] [Related]
13. Notch mediated epithelial to mesenchymal transformation is associated with increased expression of the Snail transcription factor.
Saad S; Stanners SR; Yong R; Tang O; Pollock CA
Int J Biochem Cell Biol; 2010 Jul; 42(7):1115-22. PubMed ID: 20348013
[TBL] [Abstract][Full Text] [Related]
14. BMP-2 suppresses renal interstitial fibrosis by regulating epithelial-mesenchymal transition.
Yang YL; Ju HZ; Liu SF; Lee TC; Shih YW; Chuang LY; Guh JY; Yang YY; Liao TN; Hung TJ; Hung MY
J Cell Biochem; 2011 Sep; 112(9):2558-65. PubMed ID: 21590708
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2002 Oct; 13(10):2464-77. PubMed ID: 12239235
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy.
Tan X; He W; Liu Y
Kidney Int; 2009 Dec; 76(12):1248-57. PubMed ID: 19759524
[TBL] [Abstract][Full Text] [Related]
17. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition.
Kang MK; Park SH; Choi YJ; Shin D; Kang YH
J Mol Med (Berl); 2015 Jul; 93(7):759-72. PubMed ID: 26062793
[TBL] [Abstract][Full Text] [Related]
18. Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury.
He W; Kang YS; Dai C; Liu Y
J Am Soc Nephrol; 2011 Jan; 22(1):90-103. PubMed ID: 21030600
[TBL] [Abstract][Full Text] [Related]
19. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction.
Sato M; Muragaki Y; Saika S; Roberts AB; Ooshima A
J Clin Invest; 2003 Nov; 112(10):1486-94. PubMed ID: 14617750
[TBL] [Abstract][Full Text] [Related]
20. The role of IL-7 in renal proximal tubule epithelial cells fibrosis.
Hsieh PF; Liu SF; Lee TC; Huang JS; Yin LT; Chang WT; Chuang LY; Guh JY; Hung MY; Yang YL
Mol Immunol; 2012 Feb; 50(1-2):74-82. PubMed ID: 22261356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
